Apollo Biowellness, Inc. News Releases

Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.

Wed, 08 Apr 2026 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI, Inc. (OTCQB: MWAI) to acquire Apollo and its subsidiaries including Evolutionary Biologics, Inc. ("Evo Bio"), (the "Transaction"), MWAI has reserved a Preferred Series B class of stock for the share exchanged and assumption of certain liabilities of Apollo. Negotiations are ongoing with certain...

Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc.

Tue, 10 Feb 2026 09:30:00 -0500

North Bergen, New Jersey--(Newsfile Corp. - February 10, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company) is pleased to announce the signing of a Letter of Intent ("LOI") to create a vertically integrated health, wellness and longevity platform.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10533/283349_a912020384f54aed_001full.jpgNew MedWell Ai, Inc (OTCQB: MWAI) will be organized across three core divisions: (1) national pharma...

Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.

Fri, 06 Feb 2026 09:30:00 -0500

North Bergen, New Jersey--(Newsfile Corp. - February 6, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned subsidiary of Apollo Biowellness) and Revive Regenerative, Inc. ("Revive") has been "terminated for cause" by Evolutionary Biologics, for reasons already disclosed to Revive Regenerative, Inc. and is no longer in effect.To view an enhanced version of this...

Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue

Wed, 07 Jan 2026 09:30:00 -0500

North Bergen, New Jersey--(Newsfile Corp. - January 7, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the Letter of Intent between the Company and Revive Regenerative, Inc., dated September 12, 2025, (the "LOI") has expired and it no longer in effect.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10533/279422_3bd62a33d4b12bbb_001full.jpgThe LOI contained a proposed closing date of October 31, 2025, unless extension...

Apollo Biowellness, Inc., Corporate Status and Merger Update

Wed, 29 Oct 2025 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - October 29, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce it is updating its shareholders on various developments and updates on both corporate developments and an update on the merger with Revive Regenerative, Inc. The Company will continue to update and will provide more information and greater detail over the next few weeks. In the future, we will have an update and status on the consumer based biologic...

Apollo Biowellness, Inc., Merger Update

Thu, 09 Oct 2025 14:48:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - October 9, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce that it has completed the first step in the closing process with Revive Regenerative, Inc. The Company has secured the initial tranche of capital required in the amount of $500,000 as set forth in the merger agreement. In addition, the Company has finalized with GSS Capital to raise the additional $3,000,000 needed, with the terms agreed to by both...

Apollo Biowellness, Inc., Re-Engages GSS Capital

Wed, 08 Oct 2025 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - October 8, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce that it has re-engaged GSS Capital, a licensed Investment Bank and a member of FINRA, for advisory services to assist in the restructuring of the Company's Balance Sheet, coordinate the conversion of all convertible and secured debt of the Company to allow the Company to comply with the conditions of the Letter of Intent with Revive Regenerative, Inc. ...

Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc.

Wed, 17 Sep 2025 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - September 17, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company") is pleased to announce that it has signed a Letter of Intent with Revive Regenerative, Inc. ("Revive"), a leader in the aesthetic laser and energy device industry serving plastic surgeons, dermatologists, med spas, and wellness centers, to pursue a potential merger, subject to negotiation of definitive agreements and customary closing conditions.To view an enhanced version of...

Apollo Biowellness, Inc., Launches New Product Brand

Thu, 21 Aug 2025 09:30:00 -0400

radeditorformatted_6North Bergen, New Jersey--(Newsfile Corp. - August 21, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), is pleased to announce the launch of a new self-stable biologic cosmetic.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10533/263268_a2b1b8e5841dc830_001full.jpgOur new brand is called Cielo Skin Care, and it is a full line of consumer products using self-stabilized exosome and placental based...

Apollo Biowellness, Inc., Corporate Update

Mon, 18 Aug 2025 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - August 18, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the "Company"), is pleased to announce that it has been approved to file on OTCIQ. The Company is also providing the following updates.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10533/262722_969ba78954e00ae4_001full.jpgThe Company is in final negotiations with an Israeli based Bio-Tech and Biologics manufacturer, listed on NASDAQ, for the...